Skip to main content
Premium Trial:

Request an Annual Quote

In Vitro Technologies Awarded US Patent

Premium
In Vitro Technologies has been awarded US Patent 7,351,584, “Hepatocyte bioreactor system for long term culture of functional hepatocyte spheroids.”
 
The inventors listed on the patent are Paul Silber, Nancy Cowger, Ana Miller, Lanika Brown, and Albert Li.
 
According to the abstract, a rotating wall vessel is used as a culture vessel and bioreactor for the cultivation of spheroid hepatocytes that retain many properties of the intact liver. These properties include enzyme activity comparable to fresh cells and long-term maintenance of viability and cellular function for periods as long as several months. The cultured cells may be used to produce hepatocyte products, evaluate the metabolism of potential drug candidates, propagate the hepatitis C virus, and test candidate compounds as inhibitors of this virus.

The Scan

Test of the China Initiative

According to Science, the upcoming trial of Harvard University chemist Charles Lieber will test the US China Initiative.

Collaborative Approach

A virologist who spotted the Omicron variant of SARS-CoV-2 tells the Associated Press that its detection was aided by scientific sharing.

Genes of a Guide Dog

Wired reports on a study aimed at uncovering genes involved in being a successful guide dog.

PLOS Papers on RNAs in Metastatic Prostate Cancer, Ebola Field Lab, Embryonic RNA Editing

In PLOS this week: circRNA-mediated ceRNA network points to prostate cancer biomarkers, Ebola testing at frontline field laboratory, and more.